Research & Development
API

 

Driving Innovation for Global
Healthcare

At Troikaa Pharmachem Pvt. Ltd., we are not just developing drugs—we are pioneering solutions that transform healthcare. Our commitment to scientific excellence ensures we deliver high-quality Active Pharmaceutical Ingredients (APIs) that provide patients with faster and more effective treatments. We focus on quality, speed, and flexibility in every step of our R&D process. The QbD approach sets us apart and positioned us at the forefront of the pharmaceutical industry.

Excellence Driven by Expertise and
Operational Efficiency

Our team of top-tier researchers, combined with innovative development strategies and operational excellence, has been the cornerstone of our dynamic growth in the pharmaceutical industry. We continuously invest in advanced technologies to enhance the environmental and social impact of our products and processes, designing and implementing eco-friendly methods that minimize or eliminate the use of hazardous substances.
 
 

Transforming Drug Development with Digital Science

Embracing a Quality by Design (QbD) approach integrated with our Digital Science initiatives, we incorporate Design of Experiment (DoE) methodologies to accelerate our Research and Development efforts. This integration provides robust design space and enhanced process safety along with significant reductions in drug development cycle times, improves validation success rates, and achieves substantial cost savings, enabling us to adopt a “First Time Right” approach that ensures efficiency and reliability.

Pioneering Complex API Development with Superior Quality

We specialize in the development and manufacturing of complex, technology-intensive Active Pharmaceutical Ingredients (APIs), focusing on niche molecules and challenging-to-manufacture compounds. As one of the fastest-growing companies in the country, we adhere strictly to global safety, health, and environmental standards. Our ISO-certified manufacturing facilities and cGMP-compliant processes ensure that we deliver robust, cost-effective solutions for the development of high-quality small molecules.